Objective: The widespread use of long-term enteral nutrition and the substantive costs dictate a need to study outcome, clinical and epidemiological characteristics of these patients. The aim of our study was to analyze incidence, clinical and biochemical characteristics of a cohort of patients on home enteral nutrition (HEN). Design: Prospective observational study. Setting: Tertiary care. Subjects: Between January 1999 and December 2001, all adult patients living in Valladolid West area who were discharged from the hospital on HEN were prospectively studied and followed up. Interventions: Information for each patients was prospectively recorded by the dietitian of the team, and include age, sex, body mass index, tricipital skinfold, midarm circumference, underlying disease, exitus, dates of initiation and discontinuation of HEN, nutrient formula, mode of administration and complications of HEN. During HEN, physicians supervised the home patients and the patients themselves or their close relative were asked to contact our nutrition team if any problem occurred. Finally the yearly incidence of HEN was calculated each year on the basis of the estimated population in our area of recruitment, assuming almost all HEN patients were reported. Results: In 1999, the incidence of HEN in our area was patients 15 per 100 000 inhabitants. This incidence rate rose to 21.3 in 2000 and decreased to 9.52 in 2001. The mean age of all patients was 58.7 AE 13 y. The distribution of patients by diseases was: 71 (69.6%) had a head and neck cancer; 14 (13.7%) had a neurological disorder affecting swallowing (cerebrovacular accident and/or dementia); 6 (5.9%) had tumors in different locations with anorexia; and 11 (10.8%) had one of several miscellaneous diseases inducing dysphagia or anorexia. HEN was administered orally in 81 patients (79.4%), via a nasogastric tube (NGT) in 15 patients (14.7%), via a percutaneous gastrostomy (PEG) in five patients (4.9%), and via a jejunostomy in one patient (1%). The mean duration of HEN was 101 AE 46.9 days. During the course of HEN, six patients had diarrhea (5.9%), and four (3.9%) constipation, and two vomiting (2%) that did not require cessation of HEN. Albumin, prealbumin, transferrin and lymphocytes improved in all the groups, when comparing the first review with the last. After the follow-up (3 y) with review, each 3 months, 10 of the 102 patients (9.8%) had died, and 92 (90.2%) were alive. Survival probability was influenced by the access route, with the worse outcome in patients with no oral nutrition (NGT, PEG and jejunonostomy; hazard ratio: 24.9; 95% CI: 4.1 -52), adjusted by age, sex and diagnosis. Conclusions: In conclusion, HEN is a valid and safe technique for nutrition support, with a good clinical outcome in our area.
Introduction
Enteral nutrition (EN) is the treatment of choice for patients who cannot maintain oral intake with a functioning gastrointestinal tract. Recent advances in enteral access techniques and devices have made enteral feeding more acceptable to patients, their families and physicians (Elia, 1995) . Although EN is generally required for several weeks, it does not justify keeping the patient in the hospital; on these basis home enteral nutrition (HEN) has increased in prevalence.
In the USA, the yearly prevalence of home enteral nutrition (HEN) was estimated at 415 per million population (Howard et al, 1995) . The widespread use of long-term enteral nutrition and the substantive costs dictate a need to study this nutritional therapy, and the clinical and epidemiological characteristics of these patients. The aim of our study was to analyze the incidence, clinical and biochemical characteristics of a cohort of patients on HEN.
Materials and methods

Patients and indication
Between January 1999 and December 2001, all adult patients living in Valladolid West area who were discharged from the hospital on HEN were prospectively studied and followed up. Our unit is the only institution that prescribe this treatment in the area. Informed consent was obtained in each patient.
The nutrition support team of the hospital (three doctors, one nurse and one dietitian) supervised and discussed all indications of HEN. HEN was indicated for patients with oral failure, defined as an involuntary reduction in oral intake below the minimal amount necessary to maintain proteinenergy equilibrium ( < 50% of daily adjusted by age and sex) with a functioning gut. HEN was administered via oral (patients with oral intake conserved), a nasogastric tube (NGT; patients without oral tolerance less than 6 weeks), a percutaneous enteral gastrostomy tube (PEG; patients without oral tolerance more than 6 weeks), or a jejunostomy tube (patients with major abdominal surgery). The exclusion criterion was patients with normal oral tolerance. Polymeric or semi-elementary diets were used. Four conditions had to be fulfilled to recommended HEN (1) enteral nutrition had to be initiated in the hospital, shown to be well-tolerated for a period of 10 days and the patient or a close relative had to be fully trained in the use of HEN; (2) the familial home environment had to be compatible with safe HEN delivery; (3) the patient's disease had to be sufficiently controlled and stable to allow home treatment; and (4) the expected duration of HEN had to be at least one month.
Patients were divided into two groups in the analysis, group I (oral tolerance with supplements) and group II (NGT, or PEG or jejunostomy).
Clinical characteristics
Information for each patient was prospectively recorded by the dietitian of the team, and included age, sex, body mass index, tricipital skinfold, midarm circumference, underlying disease, exitus, dates of initiation and discontinuation of HEN, nutrient formula, mode of administration and complications of HEN. During HEN, physicians supervised the home patients and the patients themselves or their close relative were asked to contact our nutrition team if any problem occurred (available 24 h). If patients or close relatives did not contact with team, the patient was reviewed each 3 months.
Finally the yearly incidence of HEN was calculated each year on the basis of the estimated population in our area of recruitment, assuming almost all HEN patients were reported.
Anthropometric and biochemical parameters Body weight was measured to an accuracy of 0.5 kg and body mass index computed as body weight=(height 2 ). Regional changes in body mass were estimated by measuring the circumferences and skinfold of the forearm. Fasting blood samples were drawn for measurement of albumin (3.5 -4.5 g=dl), prealbumin (18 -28 mg=dl), transferrin (250 -350 mg=dl), and lymphocytes (1200 -3500 Â 10 3 =ml) with an autoanalyzer (Hitachi, ATM, Manheim, Germany).
Statistical analysis
The results were expressed as mean AE standard deviation. The distribution of variables was analyzed with the KolmogorovSmirnov test. Quantitative variables with normal distribution were analyzed with two-factor repeated measures ANOVA including interaction terms. Non-parametric variables were analyzed using the Mann -Whitney U-test. Discrete variables were analyzed with the chi-square test, with Yates correction as necessary, and Fisher's test. Survival probabilities were estimated from Kaplan -Meier survival curves and compared by the log-rank test (time to event). The independent variable was survival and the explanatoy variables were age, sex, diagnosis and nutrition via. Hazard ratios and 95% confidence intervals (95% CI) were calculated by multiple logistic regression model. A P-value under 0.05 was considered statistically significant.
Results
Patients and safety
Between January 1999 and December 2001, 102 consecutive patients (89 males and 13 females) were discharged from the hospital on HEN. In 1999, the incidence of HEN in our area was patients 15 per 100 000 inhabitants (34 patients). This incidence rate rose to 21.3 in 2000 (48 patients) and decreased to 9.52 in 2001 (20 patients). The mean age of all patients was 58.7 AE 13 y. The distribution of patients by diseases was: 71 (69.6%) had a head and neck cancer; 14 (13.7%) had a neurological disorder affecting swallowing (cerebrovacular accident and=or dementia), six (5.9%) had tumors in different locations with anorexia; and 11 (10.8%) had one of several miscellaneous diseases inducing dysphagia or anorexia. HEN was administered orally in 81 patients (79.4%; group I ¼ 81 patients) , via an NGT in 15 patients (14.7%), via a PEG in five patients (4.9%), and via a jejunostomy in one patients (1%) (group II ¼ 21 patients).
The diet was a normocaloric and polymeric formula in 25.2% of patients, hypercaloric and polymeric in 15.8% patients, hyperproteic and polymeric in 38.3% patients, a
Home enteral nutrition DA de Luis et al semielementary formula in 3% patients, and an immunomodulatory formula in 17.7% patients. In patients with no oral administration, the infusion was continuous in three patients (2.9%), cyclic in three patients (2.9%) and by bolus in 15 patients (14.7%). In all patients nutrients were administered by gravity. A total of six patients (5.8%) were rehospitalized after starting HEN, for a complication of enteral nutrition, mainly tube replacement or blockage. During the course of HEN, six patients had diarrhea (5.9%), four (3.9%) constipation, and two vomiting (2%) that did not require cessation of HEN. No lung aspiration was detected. Hypernatremia (sodium > 145 meq=l) appeared only in one case (0.98%). Six patients (5.8%) reported at least one problem with the tube. HEN was stopped because of HEN intolerance in three patients (tube intolerance (one), and psycologcical intolerance (two)). No infection, leakage or bleeding were detected at the tube site. Table 1 shows demographic characteristics of groups I and II. Table 2 shows the results of several biochemical indices of nutrition status. Albumin, prealbumin, transferrin and lymphocytes improved in both groups, when compared first review with the last. Table 2 shows improvement of BMI, tricipital skinfold and midarm circumference in the both groups. No differences were detected in biochemical and anthropometric parameters among different groups of diseases.
Biochemical and anthropometric parameters
Outcomes
The mean duration of HEN was 101 AE 46.9 days. After the follow-up, 10 of the 102 patients (9.8%) had died, and 92 (90.2%) were alive. The patients with poor prognosis were patients with head and neck cancer at an advanced stage. Survival probability was influenced by the access route, with the worse outcome in patients with no oral nutrition (group II: NG tube, PEG and jejunonostomy). This was the only independent variable associated with survival probability. In multivariant analysis, an independent factor associated with death was via of nutrition with the best prognosis in oral nutrition (group I, only supplements; hazard ratio: 24.9; 95% CI: 4.1 -52), adjusted by age, sex and diagnosis.
At the end of the study registration, 68% of patients were able to resume enough oral intake for the enteral support to be discontinued and 32% continued receiving enteral nutrition support.
Discussion
Our study addressed the incidence of HEN among 21.3 and 9.5 per 100 000 inhabitants. These incidences are close to the median incidence reported in a European survey: 13.5 patients per 1 000 000 inhabitants (Hebuterne et al, 1999) . Use of HEN in the USA is much more frequent than in European countries (Howard et al, 1995) . Perhaps these differences are due to recognized differences in medical practice and economic factors (Elia, 1995) .
As in many other studies, dysphagia related to neurologic impairment of swallowing, or head and neck cancer, was the major indication for HEN. In the Spain National register, the most common indication for HEN is also neoplasias (39%; Gomez Candela et al, 1999) and the second most common indication is neurological disorders. In our study the death rate (9.8%) was lower than the Spain National register, 17%. The most common access route was oral, followed by a nasogastric tube, PEG and jejunostomy. These results are the same as those reported in our country (Gomez Candela et al, 1999; Castillo Rabaneda et al, 1998) .
Enteral nutrition was well tolerated and was able to provide complete nutrition in our population. Complications occurred in a low percentage of the patients. The gastrointestinal complications were comparable to rates in other studies (Hull et al, 1993) . In our study, no aspiration pneumonias occurred; other studies have shown a high incidence of aspiration pneumonia (Bordel-Marchasson et al, 1997) ; perhaps these differences are due to the good 10.5 AE 6.5 11.4 AE 8.5 11.6 AE 8.4* Circumference arm (cm) 22.8 AE 3.4 22.9 AE 9.4 26.7 AE 9* *P < 0.05, differences between first revision and third revisions. Baseline: hospital discharge.
mental status of our patients with a low prevalence of neurological disorders. All the deaths in this series were caused by the underlying illness. Overall, HEN patients had a good outcome, and the mortality rate was low; in other studies HEN patients had a poorer outcome (Schneider et al, 2001 ). An explanation is the different age in these patients, our patients having a median age of 50 y, 20 y younger than in other studies. However, nearly 70% of them had discontinuation HEN, emphasizing in this group the important role provided by the nutrition support team in repeating evaluations to determine whether improvements in swallowing allow the discontinuation of enteral nutrition.
Recently, some studies have reported poor outcome in some patients on HEN (Wicks et al, 1992) . In our study no differences were detected among diagnosis groups, and a good survival was achieved in relation to the good mental status of patients with a high rate of patients with only oral supplementation.
In conclusion, HEN is a valid and safe technique for nutrition support, with a good clinical outcome and incidence according to our area.
